Skip to main content
Skip to footer
Latest
AI
Climate
Consumer
Deeptech
Defense
Fintech
Healthtech
SaaS
subscribe
Tag:
swiss biotech
Mabylon secures CHF 30M for peanut allergy treatment
August 12, 2025
Swiss biotech Mabylon raises CHF 30M for peanut therapy
August 12, 2025Swiss biotech Mabylon raises CHF 30M for peanut therapy